America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.  Claims of ...

The healthcare company will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss ...

On Friday, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Wegovy for the treatment of ...

Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 ...

Taking meds to lose weight has been surging among Americans. While these drugs are safe, they have one drawback, they can also cause muscle mass loss.

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...

GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications ...